MS patients with active disease (ie, those exhibiting worsening neurological dysfunction) express more HERVW-Env proteins on the cell surface of PBMCs than healthy control subjects or MS patients in remission [74]. The gene discussed is ERVW-1; the disease is myeloid sarcoma.